Photobiomodulation Therapy Using the MuReva Phototherapy System to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Patients with Head and Neck Cancer Receiving Radiation Therapy with or without Concurrent Chemotherapy

About this Study

The overall purpose of this clinical study is to evaluate safety and
efficacy of the MuReva Phototherapy System with a light delivery
mouthpiece to reduce the severity of oral mucositis (OM) in adult
patients with squamous cell carcinoma of the oral cavity, oropharynx,
tonsils and base of tongue receiving radiation therapy with or without
concurrent chemotherapy.

Sponsor Protocol ID:LLD-001
IRB Number:2022-389
Actively Enrolling
Early Phase 1
November 20, 2023
Eligibility Criteria
22 years old
Both Male and Female
Categories Click category to view its trials.
Participating Locations
Cancer Center and Research Institute - UMMC
University Hospital - UMMC
Contact Information
Contact Name: Jennifer Barnes
Phone Number: 601-815-4540
Principal Investigator:Anne Kane
How to participate in our Clinical Trials